2020 Volume 6, Issue 13, eaay6441
Over thousands of monoclonal antibodies (mAbs) have been produced so far, and it would be valuable if these mAbs could be directly converted into catalytic antibodies. We have designed a system to realize the above concept by deleting Pro<jats:sup>95</jats:sup>, a highly conserved residue in CDR-3 of the antibody light chain. The deletion of Pro<jats:sup>95</jats:sup> is a key contributor to catalytic function of the light chain. The S35 and S38 light chains have identical amino acid sequences except for Pro<jats:sup>95</jats:sup>. The former, with Pro<jats:sup>95</jats:sup> did not show any catalytic activity, whereas the latter, without Pro<jats:sup>95</jats:sup>, exhibited peptidase activity. To verify the generality of this finding, we tested another light chain, T99wt, which had Pro<jats:sup>95</jats:sup> and showed little catalytic activity. In contrast, a Pro<jats:sup>95</jats:sup>-deleted mutant enzymatically degraded the peptide substrate and amyloid-beta molecule. These two cases demonstrate the potential for a new method of creating catalytic antibodies from the corresponding mAbs.
Archived Files and Locations
|application/pdf 1.0 MB ||
Open Access Publication
In ISSN ROAD
In Keepers Registery
access all versions, variants, and formats of this works (eg, pre-prints)